Adverse events76

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 76

Type	Event	Organ system	Group	Affected	At risk	Events
other	Leukocytosis	Blood and lymphatic system disorders	Golimumab 50 mg Alternating With Placebo	0	68	0
other	Leukocytosis	Blood and lymphatic system disorders	Mavrilimumab 100 mg	2	70	2
other	Diarrhoea	Gastrointestinal disorders	Golimumab 50 mg Alternating With Placebo	0	68	0
other	Diarrhoea	Gastrointestinal disorders	Mavrilimumab 100 mg	2	70	2
other	Gastrooesophageal reflux disease	Gastrointestinal disorders	Golimumab 50 mg Alternating With Placebo	1	68	1
other	Gastrooesophageal reflux disease	Gastrointestinal disorders	Mavrilimumab 100 mg	1	70	1
other	Nausea	Gastrointestinal disorders	Golimumab 50 mg Alternating With Placebo	1	68	2
other	Nausea	Gastrointestinal disorders	Mavrilimumab 100 mg	1	70	1
other	Fatigue	General disorders	Golimumab 50 mg Alternating With Placebo	2	68	2
other	Fatigue	General disorders	Mavrilimumab 100 mg	1	70	1
other	Influenza like illness	General disorders	Golimumab 50 mg Alternating With Placebo	0	68	0
other	Influenza like illness	General disorders	Mavrilimumab 100 mg	2	70	3
other	Pyrexia	General disorders	Golimumab 50 mg Alternating With Placebo	2	68	2
other	Pyrexia	General disorders	Mavrilimumab 100 mg	0	70	0
other	Bronchitis	Infections and infestations	Golimumab 50 mg Alternating With Placebo	1	68	1
other	Bronchitis	Infections and infestations	Mavrilimumab 100 mg	1	70	1
other	Ear infection	Infections and infestations	Golimumab 50 mg Alternating With Placebo	1	68	1
other	Ear infection	Infections and infestations	Mavrilimumab 100 mg	1	70	1
other	Herpes simplex	Infections and infestations	Golimumab 50 mg Alternating With Placebo	0	68	0
other	Herpes simplex	Infections and infestations	Mavrilimumab 100 mg	2	70	2

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01715896/events

API reference For AI assistants

Adverse events76

Sources 3

Read this list from software.